Compass Therapeutics currently has over 15 antibody, antibody combination and bispecific programs advancing through preclinical development, targeting multiple pathways of significance for the immune system. The company's offices, labs and vivarium are based in Kendall Square in Cambridge, Mass. Compass currently has approximately 70 full-time employees.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/12/18 | $132,000,000 | Series A |
Alexandria Venture Investments Biomatics Capital Biomed Realty Ventures Borealis Ventures Cowen Investments F-Prime Capital Partners OrbiMed Advisors  Thiel Capital Ulysses Holdings | undisclosed |
